AI assistant
PFIZER INC — Director's Dealing 2023
Feb 28, 2023
29831_dirs_2023-02-28_ee9d1474-ea8c-44ea-a58e-4b2a04a5b159.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2023-02-25
Reporting Person: SUSMAN SALLY (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-25 | Common Stock | M | 72984.0000 | $22.8900 | Acquired | 209179.0000 | Direct |
| 2023-02-25 | Common Stock | F | 22413.0000 | $41.7500 | Disposed | 186766.0000 | Direct |
| 2023-02-25 | Common Stock | F | 32455.0000 | $43.4400 | Disposed | 154311.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-25 | Stock Appreciation Rights | $22.8900 | M | 72984.0000 | Disposed | 2023-02-25 | Common Stock (72984.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 772.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: Price is the closing price of Pfizer common stock on February 24, 2023.
F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.